Table 7.
Reference | [42] | [43] | [34] | [35] | [36] | [37] | [38] | [39] | [40] | [41] |
---|---|---|---|---|---|---|---|---|---|---|
Taxa/Method | YF | PR | Ill Miseq | Ill Hiseq | Ro | |||||
Unclassified | < | |||||||||
Alpha-proteobacteria, Bradyrhizobiaceae, unspec | < | |||||||||
OTU 469 (o1 = one OTU) | > | |||||||||
Gamma-Proteobacteria, Enterobacteriaceae, Unspec | < | < | ||||||||
Gamma-Proteobacteria, Enterobacteriaceae, Escherichia/Shigella | < | |||||||||
Gamma-Proteobacteria, Enterobacteriaceae, Proteus | < | |||||||||
Gamma-Proteobacteria, Moraxellaceae, Unspec | < | |||||||||
Gamma-Proteobacteria, Moraxellaceae, Acinetobacter | < | |||||||||
Gamma-Proteobacteria, Pasteurellaceae, unspec. | > |
This table shows the significant relative changes in the Firmicutes phyla between PD patients (PD) and healthy controls (HC), that were assessed by the 10 summarized Parkinson’s disease studies. > symbolizes a higher abundance in HC when compared to PD; < symbolizes a lower abundance in HC when compared to PD; empty cells symbolize, that no significant change in PD compared to HC was found with the chosen methodological approach. The methods used by the studies are Yakult Intestinal Flora-SCAN (YF), 96-well block of the ABI PRISM 7900HT Sequence Detection System (PR), Illumina Miseq sequencing (Ill Miseq), Illumina Hiseq sequencing (Ill Hiseq), Roche 454 GS FLX Titanium sequencing (Ro).